カテゴリー： Market Monitor Global, 世界, 医療/バイオ

医療用美容薬のグローバル市場展望 2023年-2029年：ダーマフィラー、ボツリヌストキシン、バストインプラント、その他

◆英語タイトル：Medical Aesthetic Drugs Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23DC14413）

◆商品コード：MMG23DC14413
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年12月
◆ページ数：116
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の医療用美容薬市場規模と予測を収録しています。・世界の医療用美容薬市場：売上、2018年-2023年、2024年-2029年
・世界の医療用美容薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の医療用美容薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「ダーマフィラー」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

医療用美容薬のグローバル主要企業は、Allergan、 Galderma、 LG Life Science、 Merz Aesthetics、 Ipsen、 Syneron Medical、 Cynosure、 Mentor Worldwide、 Medytox、 Valeant Pharmaceuticals、 Fosun Pharma、 Teoxane、 Bloomage、 GC Aesthetics、 Suneva Medical、 Revance Therapeutics、 Sinclair Pharma、 Prollenium、 Lumenis、 Hologic、 Bloomage Biotechnology Corporation Limited、 Shanghai Shyndec Pharmaceutical Co., Ltd.、 Lancy Co., Ltd.、 Aoyuan Beauty Valley Technology Co., Ltd.、 Huadong MEDICINE Co., Ltd.、 Shanghai Fosun Pharmaceutical (Group) Co., Ltd.、 Lushang Freda Pharmaceutical Co., Ltd.、 Guangdong Marubi Biotechnology Co., Ltd.、 Shenzhen Lifotronic Technology Co., Ltd.などです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、医療用美容薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の医療用美容薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の医療用美容薬市場：タイプ別市場シェア、2022年
・ダーマフィラー、ボツリヌストキシン、バストインプラント、その他

世界の医療用美容薬市場：用途別、2018年-2023年、2024年-2029年
世界の医療用美容薬市場：用途別市場シェア、2022年
・美顔注射、脂肪減少注射、豊胸注射、その他

世界の医療用美容薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の医療用美容薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における医療用美容薬のグローバル売上、2018年-2023年
・主要企業における医療用美容薬のグローバル売上シェア、2022年
・主要企業における医療用美容薬のグローバル販売量、2018年-2023年
・主要企業における医療用美容薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Allergan、 Galderma、 LG Life Science、 Merz Aesthetics、 Ipsen、 Syneron Medical、 Cynosure、 Mentor Worldwide、 Medytox、 Valeant Pharmaceuticals、 Fosun Pharma、 Teoxane、 Bloomage、 GC Aesthetics、 Suneva Medical、 Revance Therapeutics、 Sinclair Pharma、 Prollenium、 Lumenis、 Hologic、 Bloomage Biotechnology Corporation Limited、 Shanghai Shyndec Pharmaceutical Co., Ltd.、 Lancy Co., Ltd.、 Aoyuan Beauty Valley Technology Co., Ltd.、 Huadong MEDICINE Co., Ltd.、 Shanghai Fosun Pharmaceutical (Group) Co., Ltd.、 Lushang Freda Pharmaceutical Co., Ltd.、 Guangdong Marubi Biotechnology Co., Ltd.、 Shenzhen Lifotronic Technology Co., Ltd.

*************************************************************

・調査・分析レポートの概要
医療用美容薬市場の定義
市場セグメント
世界の医療用美容薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の医療用美容薬市場規模
世界の医療用美容薬市場規模：2022年 VS 2029年
世界の医療用美容薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの医療用美容薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の医療用美容薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：ダーマフィラー、ボツリヌストキシン、バストインプラント、その他
医療用美容薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：美顔注射、脂肪減少注射、豊胸注射、その他
医療用美容薬の用途別グローバル売上・予測

・地域別市場分析
地域別医療用美容薬市場規模 2022年と2029年
地域別医療用美容薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Allergan、 Galderma、 LG Life Science、 Merz Aesthetics、 Ipsen、 Syneron Medical、 Cynosure、 Mentor Worldwide、 Medytox、 Valeant Pharmaceuticals、 Fosun Pharma、 Teoxane、 Bloomage、 GC Aesthetics、 Suneva Medical、 Revance Therapeutics、 Sinclair Pharma、 Prollenium、 Lumenis、 Hologic、 Bloomage Biotechnology Corporation Limited、 Shanghai Shyndec Pharmaceutical Co., Ltd.、 Lancy Co., Ltd.、 Aoyuan Beauty Valley Technology Co., Ltd.、 Huadong MEDICINE Co., Ltd.、 Shanghai Fosun Pharmaceutical (Group) Co., Ltd.、 Lushang Freda Pharmaceutical Co., Ltd.、 Guangdong Marubi Biotechnology Co., Ltd.、 Shenzhen Lifotronic Technology Co., Ltd.
...

This research report provides a comprehensive analysis of the Medical Aesthetic Drugs market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Medical Aesthetic Drugs market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Medical Aesthetic Drugs, challenges faced by the industry, and potential opportunities for market players.
The global Medical Aesthetic Drugs market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Medical Aesthetic Drugs market presents opportunities for various stakeholders, including Facial Injectable, Fat Reduction. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Medical Aesthetic Drugs market. Additionally, the growing consumer demand present avenues for market expansion.
The global Medical Aesthetic Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period.
Part of Medical Aesthetic Drugs includes medications and skin care products that are used to improve skin quality, reduce skin imperfections and lighten discolouration. These products may include ingredients such as vitamin C, hyaluronic acid, squalene, and various antioxidants. Botulinum toxin (Botox) and fillers (such as hyaluronic acid) are widely used to reduce wrinkles, improve facial lines, and increase youthfulness of appearance. These treatments are usually injected by a physician. Different types of laser treatments are used to remove redness, reduce pigmentation, remove skin blemishes and reduce wrinkles. Techniques and equipment for laser treatments continue to advance to provide more effective and safe results. A number of medications and compounds have been developed to treat skin problems such as acne, pigmentation and skin laxity. These medications may require a prescription and are administered under the supervision of a physician or dermatologist. Due to the growing field of medical and aesthetic medications, it has become even more important to conduct clinical studies and regulate the safety and efficacy of products. Government and regulatory agencies have established regulations to ensure the safety and compliance of medicinal aesthetic drugs.
Key Features:
The research report on the Medical Aesthetic Drugs market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Medical Aesthetic Drugs market.
Market Overview: The report provides a comprehensive overview of the Medical Aesthetic Drugs market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Dermal Fillers, Botulinum Toxin), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Medical Aesthetic Drugs market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Medical Aesthetic Drugs market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Medical Aesthetic Drugs market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Medical Aesthetic Drugs market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Medical Aesthetic Drugs market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Medical Aesthetic Drugs market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Medical Aesthetic Drugs, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Medical Aesthetic Drugs market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Medical Aesthetic Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Dermal Fillers
Botulinum Toxin
Breast Implants
Others
Market segment by Application
Facial Injectable
Fat Reduction
Breast Implant
Others
Global Medical Aesthetic Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Allergan
Galderma
LG Life Science
Merz Aesthetics
Ipsen
Syneron Medical
Cynosure
Mentor Worldwide
Medytox
Valeant Pharmaceuticals
Fosun Pharma
Teoxane
Bloomage
GC Aesthetics
Suneva Medical
Revance Therapeutics
Sinclair Pharma
Prollenium
Lumenis
Hologic
Bloomage Biotechnology Corporation Limited
Shanghai Shyndec Pharmaceutical Co., Ltd.
Lancy Co., Ltd.
Aoyuan Beauty Valley Technology Co., Ltd.
Huadong MEDICINE Co., Ltd.
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Lushang Freda Pharmaceutical Co., Ltd.
Guangdong Marubi Biotechnology Co., Ltd.
Shenzhen Lifotronic Technology Co., Ltd.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Medical Aesthetic Drugs, market overview.
Chapter 2: Global Medical Aesthetic Drugs market size in revenue.
Chapter 3: Detailed analysis of Medical Aesthetic Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Medical Aesthetic Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Medical Aesthetic Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Medical Aesthetic Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Medical Aesthetic Drugs Overall Market Size
2.1 Global Medical Aesthetic Drugs Market Size: 2022 VS 2029
2.2 Global Medical Aesthetic Drugs Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Medical Aesthetic Drugs Players in Global Market
3.2 Top Global Medical Aesthetic Drugs Companies Ranked by Revenue
3.3 Global Medical Aesthetic Drugs Revenue by Companies
3.4 Top 3 and Top 5 Medical Aesthetic Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Medical Aesthetic Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Medical Aesthetic Drugs Players in Global Market
3.6.1 List of Global Tier 1 Medical Aesthetic Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Medical Aesthetic Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Medical Aesthetic Drugs Market Size Markets, 2022 & 2029
4.1.2 Dermal Fillers
4.1.3 Botulinum Toxin
4.1.4 Breast Implants
4.1.5 Others
4.2 By Type – Global Medical Aesthetic Drugs Revenue & Forecasts
4.2.1 By Type – Global Medical Aesthetic Drugs Revenue, 2018-2023
4.2.2 By Type – Global Medical Aesthetic Drugs Revenue, 2024-2029
4.2.3 By Type – Global Medical Aesthetic Drugs Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Medical Aesthetic Drugs Market Size, 2022 & 2029
5.1.2 Facial Injectable
5.1.3 Fat Reduction
5.1.4 Breast Implant
5.1.5 Others
5.2 By Application – Global Medical Aesthetic Drugs Revenue & Forecasts
5.2.1 By Application – Global Medical Aesthetic Drugs Revenue, 2018-2023
5.2.2 By Application – Global Medical Aesthetic Drugs Revenue, 2024-2029
5.2.3 By Application – Global Medical Aesthetic Drugs Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Medical Aesthetic Drugs Market Size, 2022 & 2029
6.2 By Region – Global Medical Aesthetic Drugs Revenue & Forecasts
6.2.1 By Region – Global Medical Aesthetic Drugs Revenue, 2018-2023
6.2.2 By Region – Global Medical Aesthetic Drugs Revenue, 2024-2029
6.2.3 By Region – Global Medical Aesthetic Drugs Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Medical Aesthetic Drugs Revenue, 2018-2029
6.3.2 US Medical Aesthetic Drugs Market Size, 2018-2029
6.3.3 Canada Medical Aesthetic Drugs Market Size, 2018-2029
6.3.4 Mexico Medical Aesthetic Drugs Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Medical Aesthetic Drugs Revenue, 2018-2029
6.4.2 Germany Medical Aesthetic Drugs Market Size, 2018-2029
6.4.3 France Medical Aesthetic Drugs Market Size, 2018-2029
6.4.4 U.K. Medical Aesthetic Drugs Market Size, 2018-2029
6.4.5 Italy Medical Aesthetic Drugs Market Size, 2018-2029
6.4.6 Russia Medical Aesthetic Drugs Market Size, 2018-2029
6.4.7 Nordic Countries Medical Aesthetic Drugs Market Size, 2018-2029
6.4.8 Benelux Medical Aesthetic Drugs Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Medical Aesthetic Drugs Revenue, 2018-2029
6.5.2 China Medical Aesthetic Drugs Market Size, 2018-2029
6.5.3 Japan Medical Aesthetic Drugs Market Size, 2018-2029
6.5.4 South Korea Medical Aesthetic Drugs Market Size, 2018-2029
6.5.5 Southeast Asia Medical Aesthetic Drugs Market Size, 2018-2029
6.5.6 India Medical Aesthetic Drugs Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Medical Aesthetic Drugs Revenue, 2018-2029
6.6.2 Brazil Medical Aesthetic Drugs Market Size, 2018-2029
6.6.3 Argentina Medical Aesthetic Drugs Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Medical Aesthetic Drugs Revenue, 2018-2029
6.7.2 Turkey Medical Aesthetic Drugs Market Size, 2018-2029
6.7.3 Israel Medical Aesthetic Drugs Market Size, 2018-2029
6.7.4 Saudi Arabia Medical Aesthetic Drugs Market Size, 2018-2029
6.7.5 UAE Medical Aesthetic Drugs Market Size, 2018-2029
7 Medical Aesthetic Drugs Companies Profiles
7.1 Allergan
7.1.1 Allergan Company Summary
7.1.2 Allergan Business Overview
7.1.3 Allergan Medical Aesthetic Drugs Major Product Offerings
7.1.4 Allergan Medical Aesthetic Drugs Revenue in Global Market (2018-2023)
7.1.5 Allergan Key News & Latest Developments
7.2 Galderma
7.2.1 Galderma Company Summary
7.2.2 Galderma Business Overview
7.2.3 Galderma Medical Aesthetic Drugs Major Product Offerings
7.2.4 Galderma Medical Aesthetic Drugs Revenue in Global Market (2018-2023)
7.2.5 Galderma Key News & Latest Developments
7.3 LG Life Science
7.3.1 LG Life Science Company Summary
7.3.2 LG Life Science Business Overview
7.3.3 LG Life Science Medical Aesthetic Drugs Major Product Offerings
7.3.4 LG Life Science Medical Aesthetic Drugs Revenue in Global Market (2018-2023)
7.3.5 LG Life Science Key News & Latest Developments
7.4 Merz Aesthetics
7.4.1 Merz Aesthetics Company Summary
7.4.2 Merz Aesthetics Business Overview
7.4.3 Merz Aesthetics Medical Aesthetic Drugs Major Product Offerings
7.4.4 Merz Aesthetics Medical Aesthetic Drugs Revenue in Global Market (2018-2023)
7.4.5 Merz Aesthetics Key News & Latest Developments
7.5 Ipsen
7.5.1 Ipsen Company Summary
7.5.2 Ipsen Business Overview
7.5.3 Ipsen Medical Aesthetic Drugs Major Product Offerings
7.5.4 Ipsen Medical Aesthetic Drugs Revenue in Global Market (2018-2023)
7.5.5 Ipsen Key News & Latest Developments
7.6 Syneron Medical
7.6.1 Syneron Medical Company Summary
7.6.2 Syneron Medical Business Overview
7.6.3 Syneron Medical Medical Aesthetic Drugs Major Product Offerings
7.6.4 Syneron Medical Medical Aesthetic Drugs Revenue in Global Market (2018-2023)
7.6.5 Syneron Medical Key News & Latest Developments
7.7 Cynosure
7.7.1 Cynosure Company Summary
7.7.2 Cynosure Business Overview
7.7.3 Cynosure Medical Aesthetic Drugs Major Product Offerings
7.7.4 Cynosure Medical Aesthetic Drugs Revenue in Global Market (2018-2023)
7.7.5 Cynosure Key News & Latest Developments
7.8 Mentor Worldwide
7.8.1 Mentor Worldwide Company Summary
7.8.2 Mentor Worldwide Business Overview
7.8.3 Mentor Worldwide Medical Aesthetic Drugs Major Product Offerings
7.8.4 Mentor Worldwide Medical Aesthetic Drugs Revenue in Global Market (2018-2023)
7.8.5 Mentor Worldwide Key News & Latest Developments
7.9 Medytox
7.9.1 Medytox Company Summary
7.9.2 Medytox Business Overview
7.9.3 Medytox Medical Aesthetic Drugs Major Product Offerings
7.9.4 Medytox Medical Aesthetic Drugs Revenue in Global Market (2018-2023)
7.9.5 Medytox Key News & Latest Developments
7.10 Valeant Pharmaceuticals
7.10.1 Valeant Pharmaceuticals Company Summary
7.10.2 Valeant Pharmaceuticals Business Overview
7.10.3 Valeant Pharmaceuticals Medical Aesthetic Drugs Major Product Offerings
7.10.4 Valeant Pharmaceuticals Medical Aesthetic Drugs Revenue in Global Market (2018-2023)
7.10.5 Valeant Pharmaceuticals Key News & Latest Developments
7.11 Fosun Pharma
7.11.1 Fosun Pharma Company Summary
7.11.2 Fosun Pharma Business Overview
7.11.3 Fosun Pharma Medical Aesthetic Drugs Major Product Offerings
7.11.4 Fosun Pharma Medical Aesthetic Drugs Revenue in Global Market (2018-2023)
7.11.5 Fosun Pharma Key News & Latest Developments
7.12 Teoxane
7.12.1 Teoxane Company Summary
7.12.2 Teoxane Business Overview
7.12.3 Teoxane Medical Aesthetic Drugs Major Product Offerings
7.12.4 Teoxane Medical Aesthetic Drugs Revenue in Global Market (2018-2023)
7.12.5 Teoxane Key News & Latest Developments
7.13 Bloomage
7.13.1 Bloomage Company Summary
7.13.2 Bloomage Business Overview
7.13.3 Bloomage Medical Aesthetic Drugs Major Product Offerings
7.13.4 Bloomage Medical Aesthetic Drugs Revenue in Global Market (2018-2023)
7.13.5 Bloomage Key News & Latest Developments
7.14 GC Aesthetics
7.14.1 GC Aesthetics Company Summary
7.14.2 GC Aesthetics Business Overview
7.14.3 GC Aesthetics Medical Aesthetic Drugs Major Product Offerings
7.14.4 GC Aesthetics Medical Aesthetic Drugs Revenue in Global Market (2018-2023)
7.14.5 GC Aesthetics Key News & Latest Developments
7.15 Suneva Medical
7.15.1 Suneva Medical Company Summary
7.15.2 Suneva Medical Business Overview
7.15.3 Suneva Medical Medical Aesthetic Drugs Major Product Offerings
7.15.4 Suneva Medical Medical Aesthetic Drugs Revenue in Global Market (2018-2023)
7.15.5 Suneva Medical Key News & Latest Developments
7.16 Revance Therapeutics
7.16.1 Revance Therapeutics Company Summary
7.16.2 Revance Therapeutics Business Overview
7.16.3 Revance Therapeutics Medical Aesthetic Drugs Major Product Offerings
7.16.4 Revance Therapeutics Medical Aesthetic Drugs Revenue in Global Market (2018-2023)
7.16.5 Revance Therapeutics Key News & Latest Developments
7.17 Sinclair Pharma
7.17.1 Sinclair Pharma Company Summary
7.17.2 Sinclair Pharma Business Overview
7.17.3 Sinclair Pharma Medical Aesthetic Drugs Major Product Offerings
7.17.4 Sinclair Pharma Medical Aesthetic Drugs Revenue in Global Market (2018-2023)
7.17.5 Sinclair Pharma Key News & Latest Developments
7.18 Prollenium
7.18.1 Prollenium Company Summary
7.18.2 Prollenium Business Overview
7.18.3 Prollenium Medical Aesthetic Drugs Major Product Offerings
7.18.4 Prollenium Medical Aesthetic Drugs Revenue in Global Market (2018-2023)
7.18.5 Prollenium Key News & Latest Developments
7.19 Lumenis
7.19.1 Lumenis Company Summary
7.19.2 Lumenis Business Overview
7.19.3 Lumenis Medical Aesthetic Drugs Major Product Offerings
7.19.4 Lumenis Medical Aesthetic Drugs Revenue in Global Market (2018-2023)
7.19.5 Lumenis Key News & Latest Developments
7.20 Hologic
7.20.1 Hologic Company Summary
7.20.2 Hologic Business Overview
7.20.3 Hologic Medical Aesthetic Drugs Major Product Offerings
7.20.4 Hologic Medical Aesthetic Drugs Revenue in Global Market (2018-2023)
7.20.5 Hologic Key News & Latest Developments
7.21 Bloomage Biotechnology Corporation Limited
7.21.1 Bloomage Biotechnology Corporation Limited Company Summary
7.21.2 Bloomage Biotechnology Corporation Limited Business Overview
7.21.3 Bloomage Biotechnology Corporation Limited Medical Aesthetic Drugs Major Product Offerings
7.21.4 Bloomage Biotechnology Corporation Limited Medical Aesthetic Drugs Revenue in Global Market (2018-2023)
7.21.5 Bloomage Biotechnology Corporation Limited Key News & Latest Developments
7.22 Shanghai Shyndec Pharmaceutical Co., Ltd.
7.22.1 Shanghai Shyndec Pharmaceutical Co., Ltd. Company Summary
7.22.2 Shanghai Shyndec Pharmaceutical Co., Ltd. Business Overview
7.22.3 Shanghai Shyndec Pharmaceutical Co., Ltd. Medical Aesthetic Drugs Major Product Offerings
7.22.4 Shanghai Shyndec Pharmaceutical Co., Ltd. Medical Aesthetic Drugs Revenue in Global Market (2018-2023)
7.22.5 Shanghai Shyndec Pharmaceutical Co., Ltd. Key News & Latest Developments
7.23 Lancy Co., Ltd.
7.23.1 Lancy Co., Ltd. Company Summary
7.23.2 Lancy Co., Ltd. Business Overview
7.23.3 Lancy Co., Ltd. Medical Aesthetic Drugs Major Product Offerings
7.23.4 Lancy Co., Ltd. Medical Aesthetic Drugs Revenue in Global Market (2018-2023)
7.23.5 Lancy Co., Ltd. Key News & Latest Developments
7.24 Aoyuan Beauty Valley Technology Co., Ltd.
7.24.1 Aoyuan Beauty Valley Technology Co., Ltd. Company Summary
7.24.2 Aoyuan Beauty Valley Technology Co., Ltd. Business Overview
7.24.3 Aoyuan Beauty Valley Technology Co., Ltd. Medical Aesthetic Drugs Major Product Offerings
7.24.4 Aoyuan Beauty Valley Technology Co., Ltd. Medical Aesthetic Drugs Revenue in Global Market (2018-2023)
7.24.5 Aoyuan Beauty Valley Technology Co., Ltd. Key News & Latest Developments
7.25 Huadong MEDICINE Co., Ltd.
7.25.1 Huadong MEDICINE Co., Ltd. Company Summary
7.25.2 Huadong MEDICINE Co., Ltd. Business Overview
7.25.3 Huadong MEDICINE Co., Ltd. Medical Aesthetic Drugs Major Product Offerings
7.25.4 Huadong MEDICINE Co., Ltd. Medical Aesthetic Drugs Revenue in Global Market (2018-2023)
7.25.5 Huadong MEDICINE Co., Ltd. Key News & Latest Developments
7.26 Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
7.26.1 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Company Summary
7.26.2 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Business Overview
7.26.3 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Medical Aesthetic Drugs Major Product Offerings
7.26.4 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Medical Aesthetic Drugs Revenue in Global Market (2018-2023)
7.26.5 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Key News & Latest Developments
7.27 Lushang Freda Pharmaceutical Co., Ltd.
7.27.1 Lushang Freda Pharmaceutical Co., Ltd. Company Summary
7.27.2 Lushang Freda Pharmaceutical Co., Ltd. Business Overview
7.27.3 Lushang Freda Pharmaceutical Co., Ltd. Medical Aesthetic Drugs Major Product Offerings
7.27.4 Lushang Freda Pharmaceutical Co., Ltd. Medical Aesthetic Drugs Revenue in Global Market (2018-2023)
7.27.5 Lushang Freda Pharmaceutical Co., Ltd. Key News & Latest Developments
7.28 Guangdong Marubi Biotechnology Co., Ltd.
7.28.1 Guangdong Marubi Biotechnology Co., Ltd. Company Summary
7.28.2 Guangdong Marubi Biotechnology Co., Ltd. Business Overview
7.28.3 Guangdong Marubi Biotechnology Co., Ltd. Medical Aesthetic Drugs Major Product Offerings
7.28.4 Guangdong Marubi Biotechnology Co., Ltd. Medical Aesthetic Drugs Revenue in Global Market (2018-2023)
7.28.5 Guangdong Marubi Biotechnology Co., Ltd. Key News & Latest Developments
7.29 Shenzhen Lifotronic Technology Co., Ltd.
7.29.1 Shenzhen Lifotronic Technology Co., Ltd. Company Summary
7.29.2 Shenzhen Lifotronic Technology Co., Ltd. Business Overview
7.29.3 Shenzhen Lifotronic Technology Co., Ltd. Medical Aesthetic Drugs Major Product Offerings
7.29.4 Shenzhen Lifotronic Technology Co., Ltd. Medical Aesthetic Drugs Revenue in Global Market (2018-2023)
7.29.5 Shenzhen Lifotronic Technology Co., Ltd. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 医療用美容薬のグローバル市場展望 2023年-2029年：ダーマフィラー、ボツリヌストキシン、バストインプラント、その他(Medical Aesthetic Drugs Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

医療用美容薬のグローバル市場展望 2023年-2029年：ダーマフィラー、ボツリヌストキシン、バストインプラント、その他

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp